Obesity exacerbates MAFLD and osteoporosis by causing chronic low-grade inflammation in the liver (47), increasing insulin resistance (48), affecting leptin and lipocalin secretion (49, 50), and disrupting intestinal microcirculation (51, 52). This evidence concerns the gene LEP and obesity disorder.